On Thursday 20 May 2021, OrganoClick announced the successful completion of a directed share issue of approx. 5.8 million shares at a price of SEK 12 per share, raising proceeds of SEK 70m. The directed share issue attracted very strong interest and was subscribed by Swedish and international institutional investors, which included, among others Aktia Asset Management, Enter Fonder, eQ Asset Management, Handelsbanken Fonder and Länsförsäkringar Fondförvaltning. The price was determined through an accelerated book building process and corresponded to a 5.5 percent discount against the 10-day VWAP on Nasdaq First North Growth Market.
OrganoClick is a recurring customer and this transaction marks the second directed share issue by ABGSC in the last two years. In addition, OrganoClick is a valued customer on the research platform introduce.se.
The proceeds will be used for investments in increased production capacity, to improve financial flexibility and for general corporate purposes to support growth initiatives.
Contact